Oncogenes meet metabolism. From deregulated genes to a broader understanding of tumour physiology. Preface.
Riefke
Björn
B
GDD-Nonclinical Drug Safety, Bayer Schering Pharma AG, Berlin, Germany. Bjoern.riefke@bayerhealthcare.com
Mumberg
Dominik
D
Kroemer
Guido
G
Keun
Hector
H
Petersen
Kirstin
K
Steger-Hartmann
Thomas
T
D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism*; D009857:Oncogenes